Same-day discharge was associated with a 15% reduction in healthcare costs. 

The new analysis focused on 98 patients who presented with primary mitral regurgitation.

TAVR was associated with a consistently low risk of all-cause mortality or disabling stroke.

One previous study had suggested outcomes may improve in the afternoon, but researchers did not find that to be the case. 

Patients undergoing both procedures at once tended to be sicker, but their risk of poor outcomes did not significantly increase. 

Researchers used data from the COAPT trial to examine TEER's impact on patients from different age groups. 

The risk of all-cause mortality, stroke, major bleeding events or permanent pacemaker implantation was similar between the two valves.

All patients originally presented with a dysfunctional RVOT conduit or stented bioprosthetic pulmonary valve.

Researchers reported "significant improvements" in patients after one year. 

Age, diabetes and smoking were all also found to be “significant predictors” of reduced valve durability among SAVR patients.